{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:08:07Z","timestamp":1788930487231,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05837-1","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:28:14Z","timestamp":1788928094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond pooled analysis: sex-specific cardiovascular adverse event reporting signals with antiarrhythmic drugs in FAERS"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7199-3939","authenticated-orcid":false,"given":"Mostafa A.","family":"Khalifa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-0205","authenticated-orcid":false,"given":"Mohammad Najm","family":"Dadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layan S.","family":"Aldib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7860-8081","authenticated-orcid":false,"given":"Mariam","family":"Salem Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"issue":"6","key":"5837_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157753","volume":"11","author":"R B\u00f6hm","year":"2016","unstructured":"B\u00f6hm R et al (2016) OpenVigil FDA \u2013 inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications. PLoS ONE 11(6):e0157753. https:\/\/doi.org\/10.1371\/journal.pone.0157753","journal-title":"PLoS ONE"},{"issue":"6","key":"5837_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2165\/00044011-199713060-00005","volume":"13","author":"P Bordier","year":"1997","unstructured":"Bordier P et al (1997) Flecainide-induced increase in QRS duration and proarrhythmia during exercise. Clin Drug Investig 13(6):326\u2013337. https:\/\/doi.org\/10.2165\/00044011-199713060-00005","journal-title":"Clin Drug Investig"},{"issue":"2","key":"5837_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","volume":"20","author":"EG Brown","year":"1999","unstructured":"Brown EG, Wood L, Wood S (1999) The Medical Dictionary for Regulatory Activities (MedDRA). Drug Saf 20(2):109\u2013117. https:\/\/doi.org\/10.2165\/00002018-199920020-00002","journal-title":"Drug Saf"},{"issue":"2","key":"5837_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccep.2016.01.004","volume":"8","author":"L Chen","year":"2016","unstructured":"Chen L, Sampson KJ, Kass RS (2016) Cardiac delayed rectifier potassium channels in health and disease. Card Electrophysiol Clin 8(2):307\u2013322. https:\/\/doi.org\/10.1016\/j.ccep.2016.01.004","journal-title":"Card Electrophysiol Clin"},{"issue":"1","key":"5837_CR7","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.hrthm.2016.09.013","volume":"14","author":"E Chorin","year":"2017","unstructured":"Chorin E et al (2017) Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block. Heart Rhythm 14(1):90\u201395. https:\/\/doi.org\/10.1016\/j.hrthm.2016.09.013","journal-title":"Heart Rhythm"},{"issue":"3","key":"5837_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/bcp.12201","volume":"77","author":"B Darpo","year":"2014","unstructured":"Darpo B et al (2014) Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTcmodelling in a phase 1 study with oral rac-sotalol. Br J Clin Pharmacol 77(3):522\u2013531. https:\/\/doi.org\/10.1111\/bcp.12201","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"5837_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.36011\/cpp.2023.5.e1","volume":"5","author":"U Do","year":"2023","unstructured":"Do U (2023) Adverse reactions to antiarrhythmic drugs. Cardiovasc Prev Pharmacother 5(1):1\u201314. https:\/\/doi.org\/10.36011\/cpp.2023.5.e1","journal-title":"Cardiovasc Prev Pharmacother"},{"key":"5837_CR10","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.15.1648","author":"V Essebag","year":"2007","unstructured":"Essebag V (2007) Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med. https:\/\/doi.org\/10.1001\/archinte.167.15.1648","journal-title":"Arch Intern Med"},{"issue":"6","key":"5837_CR11","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1152\/jappl.2001.91.6.2611","volume":"91","author":"JM Evans","year":"2001","unstructured":"Evans JM et al (2001) Gender differences in autonomic cardiovascular regulation: spectral, hormonal, and hemodynamic indexes. J Appl Physiol 91(6):2611\u20132618. https:\/\/doi.org\/10.1152\/jappl.2001.91.6.2611","journal-title":"J Appl Physiol"},{"key":"5837_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmd.2024.100025","author":"MM Fashe","year":"2025","unstructured":"Fashe MM et al (2025) Impact of sex and pregnancy on hepatic CYP3A4 expression and activity in a humanized mouse model. Drug Metab Dispos. https:\/\/doi.org\/10.1016\/j.dmd.2024.100025","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"5837_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/hypertensionaha.109.131417","volume":"54","author":"EC Hart","year":"2009","unstructured":"Hart EC et al (2009) Age-related differences in the sympathetic-hemodynamic balance in men. Hypertension 54(1):127\u2013133. https:\/\/doi.org\/10.1161\/hypertensionaha.109.131417","journal-title":"Hypertension"},{"issue":"6","key":"5837_CR16","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/jpm12060870","volume":"12","author":"LC Hendriksen","year":"2022","unstructured":"Hendriksen LC et al (2022) Sex-based difference in the effect of metoprolol on heart rate and bradycardia in a population-based setting. J Pers Med 12(6):870","journal-title":"J Pers Med"},{"issue":"4","key":"5837_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.29235\/1814-6023-2022-19-4-351-363","volume":"19","author":"LV Kalatsei","year":"2022","unstructured":"Kalatsei LV, Snezhitskiy VA (2022) Gender electrocardiographic features in patients with drug-induced long QT syndrome caused by antiarrhythmic therapy. Proc Natl Acad Sci Belarus Med Ser 19(4):351\u2013363. https:\/\/doi.org\/10.29235\/1814-6023-2022-19-4-351-363","journal-title":"Proc Natl Acad Sci Belarus Med Ser"},{"issue":"12","key":"5837_CR18","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1113\/jphysiol.2007.150367","volume":"586","author":"J Kurokawa","year":"2008","unstructured":"Kurokawa J, Tamagawa M, Harada N, Honda S, Bai CX, Nakaya H, Furukawa T (2008) Acute effects of oestrogen on the guinea pig and human IKr channels and drug-induced prolongation of cardiac repolarization. J Physiol 586(12):2961\u201373. https:\/\/doi.org\/10.1113\/jphysiol.2007.150367","journal-title":"J Physiol"},{"issue":"5","key":"5837_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1365-2125.2009.03381.x","volume":"67","author":"C Lafuente-Lafuente","year":"2009","unstructured":"Lafuente-Lafuente C et al (2009) Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity. Br J Clin Pharmacol 67(5):511\u2013519. https:\/\/doi.org\/10.1111\/j.1365-2125.2009.03381.x","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"5837_CR20","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1161\/01.Cir.94.10.2535","volume":"94","author":"MH Lehmann","year":"1996","unstructured":"Lehmann MH et al (1996) Sex difference in risk of torsade de pointes with d,l-sotalol. Circulation 94(10):2535\u20132541. https:\/\/doi.org\/10.1161\/01.Cir.94.10.2535","journal-title":"Circulation"},{"key":"5837_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.014","author":"CM Madla","year":"2021","unstructured":"Madla CM et al (2021) Let\u2019s talk about sex: differences in drug therapy in males and females. Adv Drug Deliv Rev. https:\/\/doi.org\/10.1016\/j.addr.2021.05.014","journal-title":"Adv Drug Deliv Rev"},{"key":"5837_CR22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03510210076031","author":"RR Makkar","year":"1993","unstructured":"Makkar RR (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA. https:\/\/doi.org\/10.1001\/jama.1993.03510210076031","journal-title":"JAMA"},{"issue":"11","key":"5837_CR24","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.hrthm.2014.06.023","volume":"11","author":"KE Odening","year":"2014","unstructured":"Odening KE, Koren G (2014) How do sex hormones modify arrhythmogenesis in long QT syndrome? Sex hormone effects on arrhythmogenic substrate and triggered activity. Heart Rhythm 11(11):2107\u20132115. https:\/\/doi.org\/10.1016\/j.hrthm.2014.06.023","journal-title":"Heart Rhythm"},{"issue":"5","key":"5837_CR25","first-page":"265","volume":"1","author":"TA Plomp","year":"1987","unstructured":"Plomp TA et al (1987) Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration. In Vivo 1(5):265\u2013279","journal-title":"In Vivo"},{"issue":"4","key":"5837_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.hrthm.2018.01.027","volume":"15","author":"SD Pokorney","year":"2018","unstructured":"Pokorney SD et al (2018) Dofetilide dose reductions and discontinuations in women compared with men. Heart Rhythm 15(4):478\u2013484. https:\/\/doi.org\/10.1016\/j.hrthm.2018.01.027","journal-title":"Heart Rhythm"},{"issue":"8","key":"5837_CR27","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.hrthm.2021.04.007","volume":"18","author":"AB Rab\u00ealo Evangelista","year":"2021","unstructured":"Rab\u00ealo Evangelista AB et al (2021) Flecainide-induced QRS complex widening correlates with negative inotropy. Heart Rhythm 18(8):1416\u20131422. https:\/\/doi.org\/10.1016\/j.hrthm.2021.04.007","journal-title":"Heart Rhythm"},{"issue":"10","key":"5837_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1139\/cjpp-2018-0179","volume":"96","author":"U Ravens","year":"2018","unstructured":"Ravens U (2018) Sex differences in cardiac electrophysiology. Can J Physiol Pharmacol 96(10):985\u2013990. https:\/\/doi.org\/10.1139\/cjpp-2018-0179","journal-title":"Can J Physiol Pharmacol"},{"issue":"5","key":"5837_CR29","doi-asserted-by":"publisher","first-page":"H640","DOI":"10.1152\/ajpheart.00864.2013","volume":"307","author":"G Salama","year":"2014","unstructured":"Salama G, Bett GCL (2014) Sex differences in the mechanisms underlying long QT syndrome. Am J Physiol Heart Circ Physiol 307(5):H640\u2013H648. https:\/\/doi.org\/10.1152\/ajpheart.00864.2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"5837_CR31","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s40264-013-0075-1","volume":"36","author":"J Slattery","year":"2013","unstructured":"Slattery J, Alvarez Y, Hidalgo A (2013) Choosing thresholds for statistical signal detection with the proportional reporting ratio. Drug Saf 36(8):687\u2013692. https:\/\/doi.org\/10.1007\/s40264-013-0075-1","journal-title":"Drug Saf"},{"key":"5837_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/B978-0-12-821446-6.00014-6","volume-title":"Torsades de pointes","author":"KM Sowinski","year":"2022","unstructured":"Sowinski KM, Kovacs RJ, Tisdale JE (2022) Chapter 5 - traditional risk factors for QT interval prolongation and torsades de pointes. In: Tisdale JE (ed) Torsades de pointes. Academic Press, pp 79\u2013111. https:\/\/doi.org\/10.1016\/B978-0-12-821446-6.00014-6"},{"key":"5837_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2024.101475","volume":"54","author":"MC Tagle-Cornell","year":"2024","unstructured":"Tagle-Cornell MC et al (2024) Safety of dofetilide in stable patients and investigating traits of susceptibility to torsade de pointes. IJC Heart Vasc 54:101475. https:\/\/doi.org\/10.1016\/j.ijcha.2024.101475","journal-title":"IJC Heart Vasc"},{"issue":"6","key":"5837_CR35","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jelectrocard.2015.08.004","volume":"48","author":"J Vicente","year":"2015","unstructured":"Vicente J et al (2015) Sex differences in drug-induced changes in ventricular repolarization. J Electrocardiol 48(6):1081\u20131087. https:\/\/doi.org\/10.1016\/j.jelectrocard.2015.08.004","journal-title":"J Electrocardiol"},{"issue":"17","key":"5837_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2019.10.001","volume":"25","author":"S Watson","year":"2019","unstructured":"Watson S, Caster O, Rochon PA, den Ruijter H (2019) Reported adverse drug reactions in women and men: aggregated evidence from globally collected individual case reports during half a century. EClinicalMedicine 25(17):100188. https:\/\/doi.org\/10.1016\/j.eclinm.2019.10.001","journal-title":"EClinicalMedicine"},{"key":"5837_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad655.331","author":"M Wybraniec","year":"2023","unstructured":"Wybraniec M et al (2023a) Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II study. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehad655.331","journal-title":"Eur Heart J"},{"issue":"11","key":"5837_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.33963\/v.kp.97392","volume":"81","author":"MT Wybraniec","year":"2023","unstructured":"Wybraniec MT et al (2023b) Antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation and sex differences: insights from the CANT II study. Kardiol Pol 81(11):1089\u20131095. https:\/\/doi.org\/10.33963\/v.kp.97392","journal-title":"Kardiol Pol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05837-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05837-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05837-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:28:15Z","timestamp":1788928095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05837-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":31,"alternative-id":["5837"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05837-1","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"4 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FAERS data are publicly available and fully de-identified; institutional review board approval was therefore not required.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}